n/a: n/a

Infinity Pharmaceuticals, Inc. (INFI: NASDAQ)

$14.45 n/a | n/a%
03/26/15 - 03:59 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 165.00M 0.00 47.11M 92.77M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 165.00M 0.00 47.11M 92.77M
Selling, General, and Administrative Expenses 29.28M 27.92M 27.88M 22.72M
Research & Development 143.63M 99.76M 118.60M 108.58M
Operating Income before D & A (EBITDA) -7.92M -127.68M -99.36M -38.53M
Depreciation & Amortization 12.68M 4.02M 3.30M 4.70M
Interest Income 0.00 0.00 559.00K 326.75K
Other Income - Net 339.00K 896.00K 46.75M 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -20.26M -130.80M -55.35M -42.91M
Interest Expense 9.65M 0.00 1.91M 1.84M
Pre-Tax Income -29.91M -130.80M -57.26M -44.75M
Income Taxes 183.00K 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -17.42M -126.78M -53.96M -40.04M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -17.42M -126.78M -53.96M -40.04M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -17.42M -126.78M -53.96M -40.04M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-17.42M -126.78M -53.96M -40.04M
Preferred Dividends
Net Income Available To Common -17.42M -126.78M -53.96M -40.04M
Basic EPS from Continuing Ops. -0.36 -2.64 -1.70 -1.50
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.36 -2.64 -1.70 -1.50
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.36 -2.64 -1.70 -1.50
Basic Normalized Net Income/Share -0.36 -2.64 -1.70 -1.50
EPS fr Continuing Ops. -0.36 -2.64 -1.70 -1.50
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.36 -2.64 -1.70 -1.50
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.36 -2.64 -1.70 -1.50
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.36 -2.64 -1.70 -1.50
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with INFI

Latest INFI Headlines from TheStreet

More Financial News for INFI

Press Releases for INFI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter